INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 449m ago
HOUSE PTR49m ago
SEC 13F49m ago
ROBINHOOD CHAIN49m ago
FF
Institution

Foundation Fighting Blindness Retinal Degeneration Fund

Director, See RemarksCIK 0002042266

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 3
Max Insider Score38
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
30
FF
Foundation Fighting Blindness Retinal Degeneration FundDirector, See Remarks
IRDOpus Genetics, Inc.
Open-market sale
SELL$2.76M
556.0K sh
Sep 30, 2026Oct 2, 2026
traded Sep 30, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Opus Genetics, Inc.Director, See Remarks · Dec 11, 2025
34
FF
Foundation Fighting Blindness Retinal Degeneration FundDirector, See Remarks
IRDOpus Genetics, Inc.
Open-market sale
SELL
$7.39M
1.70M sh
May 18, 2026
May 20, 2026
traded May 18, 2026
+2d
SEC FORM 4

Evidence

38
FF
Foundation Fighting Blindness Retinal Degeneration FundDirector, See Remarks
IRDOpus Genetics, Inc.
Open-market sale
SELL$8.60M
4.00M sh
Dec 9, 2025Dec 11, 2025
traded Dec 9, 2025
+2dSEC FORM 4

Evidence